Symbol Surfing makes it fast & easy to find your next great idea. Just select a channel to get started.
The 52 Week Low is $3.55 set on Thu, May 6, 2021.
The 52 Week High is $7.86 set on Wed, Jun 24, 2020. The current price, $3.82, is 51% below the 52 Week High.
The All-Time High is $59.60 set on Mon, Apr 13, 2015. The current price, $3.82, is 94% below the All Time High.
ContraFect Corp trades on the NASDAQ. CFRX's market cap is 150.00 Million.
ContraFect Corp is a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections. Its lysin exebacase has a targeted spectrum of activity, meaning that it kills specific species of Staphylococci or closely related bacteria. Its IND candidate, CF-370, targets resistant gram-negative bacteria including Pseudomonas aeruginosa (P. aeruginosa). Its advanced clinical candidate, exebacase, is an investigational novel lysin that targets Staphylococcus aureus (Staph aureus), including methicillin-resistant (MRSA) strains, which causes serious infections such as bacteremia, pneumonia and osteomyelitis.